Login
    Neuroscience Education Institute
    • Home
    • My NEI
    • CNS Spectrums
    • Store
    • About NEI
    • Search
    • Create Account
    NEI LogoNEI Logo
    Group Membership Logo
    Search
    View Cart (0)
    Log In
    • Membership
        Membership Information
        • Sign Up or Renew
        • Overview
        • Rates
        • Groups and Institutions
        • Download Brochure
        Member Benefits
        • Patient Education
        • Master Psychopharmacology Program
        • Stahl's Essential Videos
        • Encore Presentations
        • NEI Prescribe
      • Become a Member
      • My NEI Portal
    • Meetings
        NEI Meetings
        • NEI Fall Congress
        • NEI Spring Congress
        • Saturday Morning Live
    • Practice Tools
        Practice Tools
        • NEI Prescribe (Web Access)
        • NEI Prescribe (Download App)
        • Prescriber's Guide (PDFs)
        • Clinical Toolkit
        • Patient Education
    • Teaching Tools
        Teaching Tools
        • Teaching Videos
        • Stahl's Essential Teaching Slides and Tests
        • NEI Teaching Slides
        • NEI Proctor: Master Psychopharmacology Program
    • Online CME/CE
        By Format
        • Featured Activities
        • On Demand Videos
        • Cases
        • Articles
        • Animations
        • Self-Assessments (MOC)
        • Certificate Program
        By Specialty
        • Primary Care
        • Pediatric
    • My NEI
    NEI Clinical Toolkit Logo I'm not a member - tell me about pricing
    ← Back
    Side Effect Management

    Medication-Induced Rash

    October 22, 2025
    Medication-Induced Rash
    Rashes and Psychotropic Medications
    Rash can occur with any medication. Of particular concern is the possibility of serious rash, such as Stevens-Johnson syndrome (SJS). Proper clinical management when prescribing medications involves taking steps to minimize the risk of rash, knowing how to distinguish between benign and serious rash, and knowing what to do if serious rash occurs.
    Rashes Medication Treatment
    Acne Lithium Standard acne treatments
    Hives or urticaria Any drug Antihistamines
    Psoriasis Lithium Topical steroids, vitamin D cream, topical retinoids, salicylic acid, coal tar, UV light, psoralen plus UV A
    Purpura Carbamazepine Drug discontinuation; treatment of underlying disorder
    Seborrhea Divalproex Medicated shampoos, topical antifungals, topical steroids
    Stevens-Johnson syndrome Bupropion, carbamazepine, chlorpromazine, divalproex, lamotrigine, venlafaxine, zonisamide Cessation of causal agent, systemic steroids sometimes administered early in course of illness; monitoring of electrolytes, avoidance of suprainfections or sepsis

    Clinical Distinctions Between Benign Rash and Serious Rash
    Benign Rash Serious Rash (occurs in less than 1% of patients)
    Peaks within days, settles in 10–14 days
    Spotty, nonconfluent, nontender
    Has no systemic features, laboratory tests are normal
    Confluent and widespread, or purpuric or tender
    Any prominent involvement of neck or upper trunk
    Any involvement of eyes, lips, mouth, etc.
    Any associated fever, malaise, pharyngitis, anorexia, or lymphadenopathy
    Abnormal laboratory tests for complete blood count, liver function, urea, creatinine

    Minimizing the Risk of Rash
    Do not start within 2 weeks of a viral infection, rash, or vaccination
    Avoid new medications, foods, or products during the first 3 months to decrease the risk of unrelated rash
    Patient should report any symptoms of hypersensitivity immediately (fever; flu-like symptoms; rash; any blisters; swelling of eyelids, conjunctivitis, lymphadenopathy)

    What If a Rash Develops?
    Ask patient about timing of rash, all medications/doses being taken, any changes in dose or adherence, and any novel environmental exposures
    True drug rashes are commonly on the trunk, exanthematous (eruptive), and morbilliform (measles-like in appearance)
    Rashes that occur within the first 5 days or after 8–12 weeks of treatment are rarely drug-related (for late-emerging rash, consider the possibility of formulation substitution)
    Urticarial wheal-and-flare rash (vaccine) is a probable allergic reaction—assess for other potentially serious manifestations of impending anaphylaxis
    Rash with Benign Characteristics Rash with Serious Characteristics
    Reduce medication dose or stop dosage increase Stop medication (for lamotrigine, also stop valproate if administered)
    Warn patient to stop drug and contact prescriber if rash worsens or new symptoms emerge Monitor and investigate organ involvement (hepatic, renal, hematologic)
    Prescribe antihistamine and/or topical corticosteroid for pruritis Patient may require hospitalization
    Monitor patient closely Monitor patient very closely

    Is Rechallenge an Option After Rash?
    For benign rash that resolves after drug cessation: Yes

    Related Practice Resources
    Article
    Mountains or Mole Hills? How to Effectively Manage Medication-Induced Rash
    Patient Education
    Medication Guides

    Adapted from NEI Prescribe. Copyright © Neuroscience Education Institute. The information in this site is constantly subject to scientific research and information may change.
    ← Back
    • ACCESS
    • Become a Member
    • Create an Account
    • Join Our Mailing List
    • Download NEI Prescribe
    • Download NEI Learn
    • MEMBERSHIP
    • Join Now
    • Membership Benefits
    • Membership Rates
    • Groups and Institutions
    • MEETINGS
    • NEI Fall Congress
    • NEI Spring Congress
    • NEI Saturday Morning Live
    • ON DEMAND
    • Featured CME Activities
    • News and Updates
    • Encore Presentations
    • Master Psychopharmacology Program
    • NEI Podcast
    • ABOUT
    • About Us
    • Contact Us
    • Accreditation
    • Testimonials


    NEI Logo
    HMP Global Logo
    HMP Education Logo
    HMP Omnimedia Logo
    HMP Europe Logo
    © 2025 HMP Global. All Rights Reserved.
    Terms of Use Privacy Policy
    © Copyright © 2025 by Neuroscience Education Institute. All rights reserved. Terms Of Use Privacy Statement